296 related articles for article (PubMed ID: 12090811)
21. Lithium therapy in the treatment of manic-depressive illness. Present status and future perspectives. A critical review.
Emilien G; Maloteaux JM; Seghers A; Charles G
Arch Int Pharmacodyn Ther; 1995; 330(3):251-78. PubMed ID: 8836446
[TBL] [Abstract][Full Text] [Related]
22. The effects of lithium and anticonvulsants on brain structure in bipolar disorder.
Germaná C; Kempton MJ; Sarnicola A; Christodoulou T; Haldane M; Hadjulis M; Girardi P; Tatarelli R; Frangou S
Acta Psychiatr Scand; 2010 Dec; 122(6):481-7. PubMed ID: 20560901
[TBL] [Abstract][Full Text] [Related]
23. Unlike lithium, anticonvulsants and antidepressants do not alter rat brain myo-inositol.
McGrath BM; Greenshaw AJ; McKay R; Slupsky CM; Silverstone PH
Neuroreport; 2007 Oct; 18(15):1595-8. PubMed ID: 17885608
[TBL] [Abstract][Full Text] [Related]
24. Effects of chronic clozapine administration on markers of arachidonic acid cascade and synaptic integrity in rat brain.
Kim HW; Cheon Y; Modi HR; Rapoport SI; Rao JS
Psychopharmacology (Berl); 2012 Aug; 222(4):663-74. PubMed ID: 22414961
[TBL] [Abstract][Full Text] [Related]
25. Lithium and valproic acid treatment effects on brain chemistry in bipolar disorder.
Friedman SD; Dager SR; Parow A; Hirashima F; Demopulos C; Stoll AL; Lyoo IK; Dunner DL; Renshaw PF
Biol Psychiatry; 2004 Sep; 56(5):340-8. PubMed ID: 15336516
[TBL] [Abstract][Full Text] [Related]
26. Lithium modifies brain arachidonic and docosahexaenoic metabolism in rat lipopolysaccharide model of neuroinflammation.
Basselin M; Kim HW; Chen M; Ma K; Rapoport SI; Murphy RC; Farias SE
J Lipid Res; 2010 May; 51(5):1049-56. PubMed ID: 20040630
[TBL] [Abstract][Full Text] [Related]
27. Mood stabilizers and ion regulation.
El-Mallakh RS; Huff MO
Harv Rev Psychiatry; 2001; 9(1):23-32. PubMed ID: 11159930
[TBL] [Abstract][Full Text] [Related]
28. Topiramate does not alter expression in rat brain of enzymes of arachidonic acid metabolism.
Ghelardoni S; Bazinet RP; Rapoport SI; Bosetti F
Psychopharmacology (Berl); 2005 Jul; 180(3):523-9. PubMed ID: 15719218
[TBL] [Abstract][Full Text] [Related]
29. In vivo approaches to quantifying and imaging brain arachidonic and docosahexaenoic acid metabolism.
Rapoport SI
J Pediatr; 2003 Oct; 143(4 Suppl):S26-34. PubMed ID: 14597911
[TBL] [Abstract][Full Text] [Related]
30. The effect of chronic lithium on arachidonic acid release and metabolism in rat brain does not involve secretory phospholipase A2 or lipoxygenase/cytochrome P450 pathways.
Weerasinghe GR; Rapoport SI; Bosetti F
Brain Res Bull; 2004 Jul; 63(6):485-9. PubMed ID: 15249113
[TBL] [Abstract][Full Text] [Related]
31. Latest therapies for bipolar disorder. Looking beyond lithium.
Goldberg JF; Citrome L
Postgrad Med; 2005 Feb; 117(2):25-6, 29-32, 35-6. PubMed ID: 15745123
[TBL] [Abstract][Full Text] [Related]
32. Pharmacologic loading in the treatment of acute mania.
Keck PE; McElroy SL; Bennett JA
Bipolar Disord; 2000 Mar; 2(1):42-6. PubMed ID: 11254019
[TBL] [Abstract][Full Text] [Related]
33. Gabapentin's minimal action on markers of rat brain arachidonic acid metabolism agrees with its inefficacy against bipolar disorder.
Reese EA; Cheon Y; Ramadan E; Kim HW; Chang L; Rao JS; Rapoport SI; Taha AY
Prostaglandins Leukot Essent Fatty Acids; 2012; 87(2-3):71-7. PubMed ID: 22841517
[TBL] [Abstract][Full Text] [Related]
34. The lithium ion: a foundation for psychopharmacological specificity.
Soares JC; Gershon S
Neuropsychopharmacology; 1998 Sep; 19(3):167-82. PubMed ID: 9653704
[TBL] [Abstract][Full Text] [Related]
35. Chronic olanzapine treatment decreases arachidonic acid turnover and prostaglandin E₂ concentration in rat brain.
Cheon Y; Park JY; Modi HR; Kim HW; Lee HJ; Chang L; Rao JS; Rapoport SI
J Neurochem; 2011 Oct; 119(2):364-76. PubMed ID: 21812779
[TBL] [Abstract][Full Text] [Related]
36. Topiramate does not alter the kinetics of arachidonic or docosahexaenoic acid in brain phospholipids of the unanesthetized rat.
Lee HJ; Ghelardoni S; Chang L; Bosetti F; Rapoport SI; Bazinet RP
Neurochem Res; 2005 May; 30(5):677-83. PubMed ID: 16176072
[TBL] [Abstract][Full Text] [Related]
37. Chronic imipramine but not bupropion increases arachidonic acid signaling in rat brain: is this related to 'switching' in bipolar disorder?
Lee HJ; Rao JS; Chang L; Rapoport SI; Kim HW
Mol Psychiatry; 2010 Jun; 15(6):602-14. PubMed ID: 18982003
[TBL] [Abstract][Full Text] [Related]
38. Regulation of brain polyunsaturated fatty acid uptake and turnover.
Chen CT; Green JT; Orr SK; Bazinet RP
Prostaglandins Leukot Essent Fatty Acids; 2008; 79(3-5):85-91. PubMed ID: 18938067
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms of action of anticonvulsants in affective disorders: comparisons with lithium.
Post RM; Weiss SR; Chuang DM
J Clin Psychopharmacol; 1992 Feb; 12(1 Suppl):23S-35S. PubMed ID: 1541715
[TBL] [Abstract][Full Text] [Related]
40. Chronic carbamazepine administration reduces N-methyl-D-aspartate receptor-initiated signaling via arachidonic acid in rat brain.
Basselin M; Villacreses NE; Chen M; Bell JM; Rapoport SI
Biol Psychiatry; 2007 Oct; 62(8):934-43. PubMed ID: 17628508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
